Investigation of 5-FU disposition after
โ
Yuko Tsukamoto; Yukio Kato; Masako Ura; Ikuo Horii; Tohru Ishikawa; Hideo Ishits
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 274 KB
๐ 2 views
## Abstract The nonlinear pharmacokinetics of capecitabine, a triple prodrug of 5โFU preferentially activated in tumour tissues, was investigated in human cancer xenograft models. A physiologically based pharmacokinetic (PBPK) model integrating the activation process of capecitabine to 5โFU and 5โF